Success Metrics

Clinical Success Rate
95.7%

Based on 110 completed trials

Completion Rate
96%(110/115)
Active Trials
10(7%)
Results Posted
36%(40 trials)
Terminated
5(3%)

Phase Distribution

Ph phase_1
22
15%
Ph not_applicable
28
19%
Ph phase_2
47
32%
Ph phase_3
36
25%
Ph phase_4
11
8%
Ph early_phase_1
2
1%

Phase Distribution

24

Early Stage

47

Mid Stage

47

Late Stage

Phase Distribution146 total trials
Early Phase 1First-in-human
2(1.4%)
Phase 1Safety & dosage
22(15.1%)
Phase 2Efficacy & side effects
47(32.2%)
Phase 3Large-scale testing
36(24.7%)
Phase 4Post-market surveillance
11(7.5%)
N/ANon-phased studies
28(19.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

110 of 120 finished

Non-Completion Rate

8.3%

10 ended early

Currently Active

10

trials recruiting

Total Trials

146

all time

Status Distribution
Active(15)
Completed(110)
Terminated(10)
Other(11)

Detailed Status

Completed110
unknown10
Recruiting7
Withdrawn5
Terminated5
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
146
Active
10
Success Rate
95.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.4%)
Phase 122 (15.1%)
Phase 247 (32.2%)
Phase 336 (24.7%)
Phase 411 (7.5%)
N/A28 (19.2%)

Trials by Status

enrolling_by_invitation21%
withdrawn53%
not_yet_recruiting32%
completed11075%
active_not_recruiting32%
recruiting75%
unknown107%
suspended11%
terminated53%

Recent Activity

Clinical Trials (146)

Showing 20 of 146 trialsScroll for more
NCT06693648Phase 3

A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Completed
NCT07521137Phase 2

Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence

Not Yet Recruiting
NCT04301765Phase 2

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Recruiting
NCT07072468Phase 2

Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)

Recruiting
NCT02173756Phase 3

Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults

Terminated
NCT07254429Phase 2

COMPASS - COpenhagen MenoPAuSe Study

Recruiting
NCT07431476Phase 4

Brimonidine 0.33% for Rosacea-Related Facial Erythema

Completed
NCT05776459Phase 2

Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

Active Not Recruiting
NCT07281404Early Phase 1

FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL

Not Yet Recruiting
NCT07135674Phase 4

Evaluation of a Herbal Antiseptic Gel as a Supportive Treatment for Teeth Cleaning in Patients With Periodontal Disease

Completed
NCT07062224Not Applicable

Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB)

Not Yet Recruiting
NCT06905561Not Applicable

Topical Diclofenac for Prevention of Radiation-induced Dermatitis

Recruiting
NCT06725095Not Applicable

Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis

Enrolling By Invitation
NCT06980675Not Applicable

Ozonized Olive Oil in the Treatment of Periodontal Pockets

Recruiting
NCT06872749Not Applicable

Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity

Completed
NCT06401798Not Applicable

Locally Delivered Whey Protein Nanoparticles Gel in Stage II Grade B Periodontitis

Completed
NCT06737653Not Applicable

Palatal Mucosa Wound Healing Following Antimicrobial Gel Application

Active Not Recruiting
NCT06864884Early Phase 1

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

Recruiting
NCT01449513Phase 1

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy

Completed
NCT06699654Not Applicable

"Comparison of Spirulina Gels for Treating Stage II Grade B Periodontitis"

Enrolling By Invitation

Drug Details

Intervention Type
DRUG
Total Trials
146